Select Page

Company Information – Cellecta, Inc.

Cellecta, Inc. was founded in April of 2006 by one of the chief scientists from Clontech Laboratories. The contract research company was borne out of the need for higher-quality, more advanced pooled lentiviral shRNA and peptide libraries. Our mission is to develop advanced high-throughput (HT) genetic screen technologies and their applications for the discovery and functional characterization of novel therapeutic targets and drugs.

About Us
Find out more about the history of the company and background of the scientists.

NIH Grants
A listing of NIH grants awarded to Cellecta.

Press Releases

Blog / News
Learn more about our technology as we present data and recommendations. Also, find out Celleta’s latest news.

Track our schedule of events, including presentations at Conferences and Meetings.

One of our most important assets is the company we keep.

Legal Statements
Learn about Cellecta’s intellectual property IP stance and limited label licenses.

Contact Us